Kadmos Capital

Venture capital firm based in London, UK

Latest Kadmos Capital investments

Kadmos Capital has invested in these startups.

Scindo

AI platform Scindo raises £4m led by Kadmos Capital and Clay Capital. Scindo's enzyme design platform combines AI models and validated reaction data to accelerate enzyme discovery. Read more

Outsee

Biotech

OutSee clinches £1.8M in seed funding to boost its AI tool, *Nomaly*, transforming drug discovery and advancing genomic analysis. Read more

GlycanAge

Healthtech

GlycanAge secures £3.3 million seed funding to revolutionize personalized preventative healthcare through groundbreaking glycan biomarkers, paving the way for a new era in diagnostics and disease detection. Read more

XONAI

SaaS

London-based XONAI raises $3.5M in Seed funding to develop cloud optimization solutions that reduce data infrastructure operational costs and unlock ROI immediately without changes to infrastructure, backed by Kadmos Capital, Adara Ventures, Nauta Capital, Notion Capital, Mehdi Ghissassi, and Martin Gould. Read more

Antiverse

Biotech

Antiverse Ltd is shaking up biotechnology with the discovery of eight powerful antibody clusters and a $3 million investment, paving the way for groundbreaking therapies targeting human GPCRs. Read more

Investments By Sector

Kadmos Capital has invested in these sectors

Biotech	37.5%
Healthtech	12.5%
AI	12.5%
SaaS	12.5%
Greentech	12.5%
Data	12.5%

Venture Capital Investors

Connect with VC Investors from Kadmos Capital

Remy Kesrouani

Managing Partner

John Gebeily

Co-Founder and Operating Partner at Kadmos Capital Ltd

They Have Invested With Kadmos Capital

Connect with investors related to Kadmos Capital's network

LAUNCHub Ventures

SOSV

List of pre-seed

& seed VC firms

2025 Startupmag.co.uk © Kohdao Ltd. Unit 8B Raleigh Gardens, Brixton, London, SW2 1AD, UK.
Registration 06261702. Data Protection No: ZA891746.